A reporting entity must report detailed information about their reportable OTC derivatives, referred to as "derivative transaction information” and changes to that information to a Trade Repository in accordance with Reporting DTR 2.2.3 generally no later than the end of the second business day after the reportable transaction occurs.
The derivative transaction information includes:
(a) transaction and position information including each modification, termination or assignment of a position, as in the Reporting DTRs;
(b) information on transaction maturity, price, reference entity, counterparty, valuation of positions, collateral and barrier types and other key economic terms in relation to each reportable derivative such as counterparties, notional amounts, underlying assets and transaction timestamps;
(c) product, transaction and entity identifiers;
(d) information on whether the transaction is centrally cleared; and
(e) valuation (mark-to-market, mark-tomodel or central counterparty valuation) and collateral information.
The Reporting DTRs are intended to reflect the harmonised international standards for legal entity identifiers (LEIs), unique transaction identifiers (UTIs), UPIs and critical data elements together with other specified data elements.
The UTI is a globally unique transaction identifier used in derivative transaction reporting by each party to the transaction, so that each reported transaction is solely identified by a single UTI. It provides significant regulatory benefit in terms of matching both sides of the same transaction, including avoiding double counting in market metrics such as turnover and aggregate notional principal.
Reporting DTR 2.2.9 ‘Reporting requirement - Unique transaction identifier’ requires the reporting entity or a person appointed on its behalf, to: in certain circumstances, receive and report a UTI generated by another entity; and in other circumstances, generate, report and provide a UTI to another entity. Specifically, the Rules introduce a UTI waterfall of steps to determine which party should generate the UTI. This starts with market infrastructures, then into cases of single-jurisdiction reporting, with one or both parties reporting, and then multijurisdictional reporting.
A UTI must be provided for a reportable derivative that is:
(a) an entry into of an arrangement that is an OTC derivative;
(b) an assignment of an arrangement that is an OTC derivative; or
(c) a change in the recording of an OTC derivative from representation as a transaction to representation as a position.
Both lifecycle reporting and snapshot or end of day reporting for all reportable derivatives are required under the Reporting DTRs.
9.2 ISO 20022
Schedule 1 of the Reporting DTRs contains a table that prescribes the relevant data fields, the information to be reported and the format in which it must be reported. Not all of the data fields may be applicable to a particular transaction, and a reporting entity is required to report the information "to the extent that information is relevant to the reportable derivative.”
A reporting entity must therefore ensure that its systems and processes are able to capture and report all relevant information.
Schedule 1 of the Reporting DTRs lists technical requirements for the data elements and ASIC sets out worked examples in ASIC Regulatory Guide 251 (RG 251).
The reporting requirements are also aligned with global frameworks like the ISO 20022 messaging standard, which supports seamless data exchange across jurisdictions.
9.3 What is the reporting timeframe?
At the end of the second business day after the after the day on which the reportable derivative or change occurs.
9.4 Do both parties report?
Australia’s reporting regime is “double-sided” (i.e. both parties report), subject to limited single-sided reporting relief (see below for further details).